Clinical trial NCT00180518 - References

Carotid Atherosclerosis — ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Trial"

Citation(s)

•   Gray WA, Hopkins LN, Yadav S, Davis T, Wholey M, Atkinson R, Cremonesi A, Fairman R, Walker G, Verta P, Popma J, Virmani R, Cohen DJ; ARCHeR Trial Collaborators
  Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg. 2006 Aug;44(2):258-68. Erratum in: J Vasc Surg. 2007 Jan;45(1):226.
•   Gray WA
  A cardiologist in the carotids. J Am Coll Cardiol. 2004 May 5;43(9):1602-5. Review.
•   Gray WA
  Endovascular treatment of extra-cranial carotid artery bifurcation disease. Minerva Cardioangiol. 2005 Feb;53(1):69-77. Review.
•   Illig KA, Zhang R, Tanski W, Benesch C, Sternbach Y, Green RM
  Is the rationale for carotid angioplasty and stenting in patients excluded from NASCET/ACAS or eligible for ARCHeR justified? J Vasc Surg. 2003 Mar;37(3):575-81.
•   Kasirajan K
  What is the latest in inventory for carotid stenting and cerebral protection? Perspect Vasc Surg Endovasc Ther. 2005 Jun;17(2):135-41.
•   Naylor AR
  Regarding "Protected carotid stenting in high-surgical-risk patients: the ARCHeR results". J Vasc Surg. 2007 Jan;45(1):222-3; author reply 223-4.
•   Schonholz CJ, Uflacker R, Parodi JC, Hannegan C, Selby B
  Is there evidence that cerebral protection is beneficial? Clinical data. J Cardiovasc Surg (Torino). 2006 Apr;47(2):137-41. Review.

Prospective, Non-Randomized, Multi-Center, Single-Arm Trial to Assess Safety & Efficacy of the Acculink Carotid Stent System With the Accunet Embolic Protection System in High-Risk Patients With Carotid Artery Lesions.

Details for clinical trial NCT00180518